Author Panel

Results for: cancer treatment immunotherapy

11 results found in 0.6 seconds
Search Sources
Database
Complete
11 results
PubMed/NCBI
Loading...
0 results
arXiv
Loading...
0 results
Semantic Scholar
Loading...
0 results
CrossRef
Loading...
0 results
2026 reyes2026identifying DATABASE
Identifying Disparities in Timely Receipt of Radiation After Breast-Conserving Surgery.

Reyes, Nicole; Ortega, Camila; Mendiola, Amanda; Murray, Mary; Fenton, Andrew; Brett-Morris, Adina; Mangira, Caroline

The breast journal , 2026 : 9942451

Radiation therapy after breast-conserving surgery reduces local recurrence and improves survival. The new standard set forth by the Commission on Cancer (CoC) requires that radiation be initiated in less than or equal to 60 days of definitive surgery for patients receiving breast-conserving surgery for Stages I-III breast cancer who do not undergo adjuvant chemo or immunotherapy. Timely access to radiation is critical, and yet there still exists a modest number of patients who experience delays in the initiation of radiation. We aim to highlight this disparity at our institution and identify the socioeconomic factors that contribute to it. Using the Breast Cancer Registry, we conducted a retrospective analysis of women diagnosed with Stages I-III breast cancer, who underwent breast-conserving surgery between 2011 and 2021. Women who received chemotherapy were excluded. We stratified patients based on socioeconomic and other factors and examined which factors attributed to an increased interval from surgery to initiation of radiation greater than the current standard of 60 days. A cohort of 427 women meeting the inclusion criteria was identified. Most patients received adjuvant radiation within the new standard of 60 days from definitive surgery (72.4%). However, patients of White race were significantly more likely to receive adjuvant radiation within 60 days of final surgery (74.7%) compared to patients of Black race (55.6%). In addition, patients with private insurance or Medicare were more likely to receive adjuvant radiation within the current set standard (74.9% and 74.5%, respectively) in comparison to patients with Medicaid (50.0%). This analysis identifies disparities in breast cancer treatment among minority populations at our institution. It also suggests that insurance status can affect the receipt of treatment in a recommended time frame. There is research that shows a delay in radiation impairs survival. These results indicate that improving access to timely adjuvant radiation may be leveraged to lessen disparities experienced by minority races regardless of insurance status.
2023 nwozo2023antioxidant DATABASE
Antioxidant, phytochemical, and therapeutic properties of medicinal plants: a review

Onyenibe Sarah Nwozo; Enor Magdalene Effiong; P. Aja; Chinaza Godswill Awuchi

International Journal of Food Properties

ABSTRACT Oxidation is an integral part of aerobic processes of life. It involves the transfer of electrons or hydrogen via a chemical reaction from a substance to an oxidizing agent leading to the production of free radicals. These free radicals which are highly reactive in turn initiate a chain of reactions that lead to cellular damage. The etiology of plethora diseases has been linked to the generation of free radicals beyond the body’s antioxidant capacity, leading to oxidative stress. Consequently, the focus of research has tilted toward plants which provide natural products rich in antioxidants capable of scavenging and distrupting the harmful effects of these free radicals. A large group of compounds produced by plants referred to as phytochemicals possessing high antioxidant properties have been seen to be helpful in tackling numerous diseases. This review covered the antioxidant potential of some plants with medicinal properties beneficial to people, industries, and health institutions who desire their potential benefits. A total of two hundred and fifty plants from the following families; Asteraceae, Combretaceae, Euphorbiaceae, Fabaceae, Lamiaceae, Moraceae and Malvaceae were reviewed. These plants exert important biological properties, such as anti-inflammatory, antioxidant, immunomodulatory, anticancer, and antimicrobial properties, among others.
2023 dubale2023phytochemical DATABASE
Phytochemical Screening and Antimicrobial Activity Evaluation of Selected Medicinal Plants in Ethiopia

S. Dubale; D. Kebebe; A. Zeynudin; Negera Abdissa; S. Suleman

Journal of Experimental Pharmacology

Background The emergence and spread of resistant microbes continue to be a major public health concern. Effective treatment alternatives, particularly from traditionally used medicinal plants, are needed. Objective The main objective of this study was to conduct phytochemical screening and antimicrobial activity evaluation of selected traditionally used medicinal plants in Ethiopia. Methods The ethnomedicinal use value frequency index (FI) was used to select twelve medicinal plants. Phytochemical classes of compounds were screened using different standard methods. Anti-microbial activities of plant extracts were evaluated against Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, and Candida albicans. Minimum inhibitory concentrations were measured using the broth micro-dilution method. The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 21.0 and the findings were presented descriptively and using non parametric one-way ANOVA analysis (Kruskal–Wallis/Ddunn’s test). Results The phytochemical constituents identified were flavonoids, alkaloids, glycosides, phenols, saponins, steroids, and terpenoids, with flavonoids, alkaloids, and phenols being the most abundant. The crude extracts and chloroform fractions of the extracts showed an activity against the tested strains. The crude extract of Thalictrum rhynchocarpum Quart.-Dill. and A.Rich root demonstrated superior activity against all the tested strains with the lowest minimum inhibitory concentrations of 0.48 μg/mL against Staphylococcus aureus and Escherichia coli; 0.98 μg/mL against Klebsiella pneumoniae, Pseudomonas aeruginosa; and 3.90 μg/mL against Candida albicans, which are even better than the reference drug, gentamicin and clotrimazole. Conclusion The majority of evaluated medicinal plants demonstrated remarkable activity against tested microbial strains, which can be attributed to the presence of secondary metabolites of different classes of compounds. The finding provided scientific evidence for the use of these traditionally used medicinal plants.
2023 chavda2023advanced DATABASE
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer

Vivek P. Chavda; Lakshmi Vineela Nalla; Pankti C. Balar; Rajashri Bezbaruah; V. Apostolopoulos; Rajeev K. Singla; A. Khadela; Lalitkumar K. Vora; V. Uversky

Cancers

Simple Summary Breast cancer is a concern for the healthcare system. Even with the advancement of science and technology, the current system for therapeutics and diagnostics seems to have numerous pitfalls. Phytochemical-mediated nanocarriers come into the picture to outrange the drawbacks of the conventional breast cancer management method. Phytochemicals have been a useful tool since time immemorial, and developing a sophisticated fusion of these chemicals with nanocarrier enhanced its effectiveness. This ensures targeted, time-controlled drug delivery. This article emphasizes the development of phytochemical-based nanocarriers corresponding to breast cancer. Moreover, the article presents the unhighlighted parts of the therapeutical industry to help patients. Enhancing patients’ quality of life would uplift the healthcare system. Abstract As the world’s most prevalent cancer, breast cancer imposes a significant societal health burden and is among the leading causes of cancer death in women worldwide. Despite the notable improvements in survival in countries with early detection programs, combined with different modes of treatment to eradicate invasive disease, the current chemotherapy regimen faces significant challenges associated with chemotherapy-induced side effects and the development of drug resistance. Therefore, serious concerns regarding current chemotherapeutics are pressuring researchers to develop alternative therapeutics with better efficacy and safety. Due to their extremely biocompatible nature and efficient destruction of cancer cells via numerous mechanisms, phytochemicals have emerged as one of the attractive alternative therapies for chemotherapeutics to treat breast cancer. Additionally, phytofabricated nanocarriers, whether used alone or in conjunction with other loaded phytotherapeutics or chemotherapeutics, showed promising results in treating breast cancer. In the current review, we emphasize the anticancer activity of phytochemical-instigated nanocarriers and phytochemical-loaded nanocarriers against breast cancer both in vitro and in vivo. Since diverse mechanisms are implicated in the anticancer activity of phytochemicals, a strong emphasis is placed on the anticancer pathways underlying their action. Furthermore, we discuss the selective targeted delivery of phytofabricated nanocarriers to cancer cells and consider research gaps, recent developments, and the druggability of phytoceuticals. Combining phytochemical and chemotherapeutic agents with nanotechnology might have far-reaching impacts in the future.
2022 el-beltagi2022phytochemical DATABASE
Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review

H. El-Beltagi; A. Mohamed; H. Mohamed; K. Ramadan; Aminah A Barqawi; A. Mansour

Marine Drugs

Since ancient times, seaweeds have been employed as source of highly bioactive secondary metabolites that could act as key medicinal components. Furthermore, research into the biological activity of certain seaweed compounds has progressed significantly, with an emphasis on their composition and application for human and animal nutrition. Seaweeds have many uses: they are consumed as fodder, and have been used in medicines, cosmetics, energy, fertilizers, and industrial agar and alginate biosynthesis. The beneficial effects of seaweed are mostly due to the presence of minerals, vitamins, phenols, polysaccharides, and sterols, as well as several other bioactive compounds. These compounds seem to have antioxidant, anti-inflammatory, anti-cancer, antimicrobial, and anti-diabetic activities. Recent advances and limitations for seaweed bioactive as a nutraceutical in terms of bioavailability are explored in order to better comprehend their therapeutic development. To further understand the mechanism of action of seaweed chemicals, more research is needed as is an investigation into their potential usage in pharmaceutical companies and other applications, with the ultimate objective of developing sustainable and healthier products. The objective of this review is to collect information about the role of seaweeds on nutritional, pharmacological, industrial, and biochemical applications, as well as their impact on human health.
2021 siddiqui2021phytochemical DATABASE
PHYTOCHEMICAL ANALYSIS OF SOME MEDICINAL PLANTS

Maham Siddiqui

Liaquat Medical Research Journal

Ethnobotany and Medicinal Plants of Indian SubcontinentAdvances in Plant & Microbial BiotechnologyAntimicrobial Properties of Some Nigerian Medicinal PlantsFingerprinting Analysis and Quality Control Methods of Herbal MedicinesFundamentals of Phytochemical AnalysisThe Honey Apple and its phytochemical analysisPhytochemical Analysis and Evaluation of Anticancer and Antimalarial Properties of Four Medicinal PlantsAn Ethnobotanical, Pharmacological, and Phytochemical Analysis of Achillea Millefolium L. by PartsPhytochemical Analysis and Bioactivity of Selected South African Medicinal Plants on Clinical Isolates of Helicobacter PyloriPhytochemical analysis of avocado seeds (Persea americana Mill., c.v. Hass)Phytochemical Analysis of Jatropha Gossypifolia LinnAn Experimental Text Book on Phytochemical Analysis and Antimicrobial Activity of Mentha PiperitaPhytochemicalsPhytochemical Analysis and Antimicrobial Activity of Piper Capensis L.fPhytochemistryPhytochemistry of Medicinal PlantsIndian Herbal MedicinesIsolation and Structural Elucidation of Novel Anti-Infective Naphthylisoquinoline Alkaloids from Ancistrocladus Ealaensis, and Phytochemical Analysis of Two Congolese Medicinal PlantsPhytochemical Analysis of Ficus Platyphylla Del-Holl (Moraceae)Natural Oral Care in Dental TherapyComputational PhytochemistryPhytochemical Screening, Elemental Analysis and Antibacterial Investigation of Rhoicissus TomentosaPhytochemical Analysis of Adenium Obesum Stem-BarkPhytochemical Analysis and Biological Activity Studies of an Eastern Cape Medicinal Plant, Strychnos HenningsiiPhytochemical Analysis of Some Sudanese Medicinal PlantsNatural Compounds as Antimicrobial AgentsPhytochemical Analysis of Maerua PseudopetalosaPhytochemical Analysis of Some Medicinal Plants Used Against Dysentery by the Tribals of South ChhotanagpurPhytochemical Analysis and Antibacterial ActivityHerbals of AsiaPhytochemical TechniquesAnalysis of Phytochemical in a Malaysian Medicinal Plant and the Bioavailability of Dietary HydroxycinnamatesAntifungal Evaluation and Phytochemical Analysis of Selected Medicinal Plants Used in the Treatment of Fungal Diseases Associated with HIV Infection in the Eastern Cape Province, South AfricaPhytochemistry of Ashtavarga-Rare Anti-Aging Medicinal PlantsNeutraceutical, Phytochemical characterization and Antibacterial activity of Medicinal plant Moringa OleiferaEthnomedicinal Plants with Therapeutic PropertiesPhytochemical analysis of fruit extracts of Baccaurea courtallensis and evaluation of cholesterol lowering propertyBiotechnological Advances, Phytochemical Analysis and Ethnomedical Implications of Sapindus speciesBiological and Phytochemical Analysis of Chungtia Medicinal Plants of Nagaland, IndiaStudies on the Antioxidant Activity of Indigofera Hochstetteri Baker
2001 gomez2001chemoimmunotherapy DATABASE
Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer

Gomez, G.G; Hutchison, R.B; Kruse, C.A

Cancer Treatment Reviews , 27 : (6):375-402

1987 cervical cancer immunotherapy study group1987immunotherapy DATABASE
Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer

CERVICAL CANCER IMMUNOTHERAPY STUDY GROUP

Cancer , 60 : (10):2394-2402

1976 carter1976immunotherapy DATABASE
Immunotherapy in the strategy of cancer treatment

Carter, S. K.

Cancer Immunology Immunotherapy , 1 : (3):115-118